MYC and neuroblastoma: Literature has suggested that some compounds (e.g., 10058-F4 and 10074-G5) can inhibit MAX-MYC heterodimerization and induce growth inhibition, apoptosis, and differentiation in MYCN-amplified neuroblastoma cells [17], and some compounds can prolong survival of MYCN transgenic mice [18].